Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for February 2008
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

AstraZeneca fined $200m over Medicaid pricing
Company will appeal verdict..(more)

 Dr Paul Hooper
Eisai vows to fight on with Alzheimer's appeal for patients and in memory of campaigning managing director..(more)

 New pharma-NHS collaboration in preparation
Second cancer project ready for launch this summer..(more)

 Latest news from Datamonitor
Product roundup..(more)

 Health comms agency Hive launched
Agency wants to bring the buzz back to marketing..(more)

 GlaxoSmithKline's Tyverb poised for launch in the UK
Breast cancer drug a potential blockbuster..(more)

 Latest news from Datamonitor
Clinical roundup..(more)

 Boehringer Ingelheim's anti-clotting pill ready for launch
Drug could provide a convenient alternative to warfarin..(more)

 Biovitrum to focus on specialist care
New direction aimed at retaining control of products..(more)

 Wellcome Trust boosts medical research funding
Research charity aims to help tackle world's major diseases..(more)

 NHS launches new online health A-Z index
Public resource includes information on more than 700 conditions and treatments..(more)

 Vectibix launched for bowel cancer in UK
Amgen faces struggle against Merck Serono's Erbitux..(more)

 Ministers press GPs over surgery hours
Government threatens to impose change..(more)

 Generics and Avandia decline will hold GSK back
Things will be a little bit difficult, concedes outgoing chief executive Garnier..(more)

 Britain a 'Prozac Nation', say Lib Dems
Patients waiting too long for NHS counselling services..(more)

 Takeda snaps up Amgen products
Partnership includes molecules in oncology, inflammation, neurology and pain..(more)

 Collaborations with diagnostic firms 'crucial to oncology progress'
Pharma told it should engage earlier..(more)

 Latest news from Datamonitor
Product and company roundup..(more)

 PM Society Awards
Paling Walters scoop best GP Journal Advertisement and best Hospital Journal Advertisement..(more)

 Avastin's new licence 'more cost-effective'
Roche says change could open door to more NHS funding for drug..(more)

 Yondelis launched for soft tissue sarcoma
First anti-cancer drug to be developed by a Spanish pharma company..(more)

 AstraZeneca sales strong despite Nexium's decline
Company hopes to offset decline with growth elsewhere in portfolio..(more)

 Latest news from Datamonitor
Clinical roundup..(more)

 Tamiflu resistance hits Roche
Authorities assessing significance of new data..(more)

 Torisel poised to gain lymphoma licence
Drug one step from new approval in rare type of non-Hodgkin's lymphoma..(more)

 New consortium to run NHS clinical audit programme
Department of Health divests role from the Healthcare Commission..(more)

 Government and industry agree on collaboration guidelines
Move could herald closer industry-NHS ties..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.